Home
Conditions
Dyskinesias

Clinical trial condition

Dyskinesias

Explore clinical trials studying Dyskinesias. Study availability and eligibility vary by location and protocol.

1,103 public trials 189 recruiting studies

Refine in advanced search Browse all conditions

Dyskinesias trial results

Completed

DYSCAR: Characterization of Dystonia

NCT00361465

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +11 more
Locations: Grenoble University Hospital Grenoble, France

View Trial Details

Completed

A Study To Evaluate The Efficacy And Safety Of Intramuscular Levosulpiride In Patients With Agitation Of Schizophrenia

NCT00866645

Conditions: Aberrant Motor Behavior in Dementia, Agitation, Behavior, +12 more
Locations: Hebei Mental Health Center Baoding, Hebei, China

Nanjing Brain Hospital Nanjing, Jiangsu, China

Xi'an Mental Health Center Xi'an, Shaanxi, China

Shanghai Mental Health Center Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Efficacy and Akathisia Incidence of Slow Infusion Metoclopramide

NCT01069536

Conditions: Aberrant Motor Behavior in Dementia, Akathisia, Behavior, +12 more
Locations: Not specified

View Trial Details

Completed

A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin

NCT00990613

Conditions: Alzheimer Disease, Alzheimer's Disease, Basal Ganglia Diseases, +17 more
Locations: Pfizer Investigational Site Kalamazoo, Michigan, United States

View Trial Details

Completed

Prophylaxis Against Metoclopramide-Induced Akathisia

NCT01051271

Conditions: Aberrant Motor Behavior in Dementia, Akathisia, Behavior, +9 more
Locations: Not specified

View Trial Details

Completed

Biofeedback for Dyssynergic Constipation

NCT00127257

Conditions: Ataxia, Constipation, Dyskinesias, +5 more
Locations: University of North Carolina Department of Medicine Chapel Hill, North Carolina, United States

View Trial Details

Completed

A Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine)

NCT00988624

Conditions: Alzheimer Disease, Alzheimer's Disease, Basal Ganglia Diseases, +16 more
Locations: Pfizer Investigational Site New Haven, Connecticut, United States

View Trial Details

Completed

A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function

NCT00824590

Conditions: Alzheimer Disease, Alzheimer's Disease, Basal Ganglia Diseases, +24 more
Locations: Pfizer Investigational Site Miami, Florida, United States

Pfizer Investigational Site Saint Paul, Minnesota, United States

View Trial Details

Completed

Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)

NCT00043849

Conditions: Aberrant Motor Behavior in Dementia, Basal Ganglia Diseases, Behavior, +21 more
Locations: University of Alabama at Birmingham, Alzheimer's Disease Research Center Birmingham, Alabama, United States

University of California, San Diego, Alzheimer's Disease Center La Jolla, California, United States

VA Healthcare System Long Beach Long Beach, California, United States

University of California at Los Angeles, Alzheimer's Disease Center Los Angeles, California, United States

View all 21 locations

View Trial Details

Completed

Piracetam for Treatment Tardive Dyskinesia

NCT00190008

Conditions: Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +6 more
Locations: Beersheva Mental Health Center Beersheva, Israel

View Trial Details

Dyskinesias

Dyskinesias trial results

Related conditions